The 3rd International HIV/Viral Hepatitis Co-Infection Meeting provided a unique opportunity for industry, academic, community and governmental stakeholders to interact and develop constructive solutions together that can support equitable access to modern therapeutics while maintaining sustainable innovation. The meeting provided research-based evidence to demonstrate the value of curative therapies, it engaged policy makers towards creating an environment that supports their wider therapeutic access nationally and internationally, and focused on identifying opportunities for increased diagnosis and treatment of viral hepatitis in people living with HIV (PLHIV), particularly in low and middle-income settings.
Organizing Committee
Marina Klein, Canada
Wendy Spearman, South Africa
Monique Andersson, South Africa
Isabelle Andrieux-Meyer, Switzerland
Anchalee Avihingsanon, Thailand
Sanjay Bhagani, UK
Curtis Cooper, Canada
Greg Dore, Australia
Jordan Feld, Canada
Karine Lacombe, France
Gail Matthews, Australia
Sébastien Morin, Switzerland
Marion Peters, USA
Jürgen Rockstroh, Germany
Mark Sulkowski, USA
Tracy Swan, USA
Date
Sunday, 17 July 2016
Location
Durban International Convention Centre (ICC)
Scientific Programme
HOW TO REGISTER
Registration for the 3rd International HIV/Viral Hepatitis Co-Infection Meeting is open to all AIDS 2016 delegates on a first-come basis.
20th European AIDS Conference
15-18 October 2025 Paris, France
EACS Guidelines updated
The EACS 12.1 and the app are available for free on
Educational Programme
Training and educating the next generation of clinicians and researchers is an EACS core activity.
EACS Resource Library
Access all scientific content of EACS core activities! (members only)
Interim Guidance
Interim Guidance on the Use of Statin Therapy for the Primary Prevention of Cardiovascular Disease in People with HIV